|
[1]European Association for the Study of the Liver.EASL clinical practice guidelines:Management of chronic hepatitis B virus infection[J].J Hepatol, 2012, 57 (1) :167-185.
|
|
[2]PAN CQ, DUAN Z, DAI E, et al.Tenofovir to prevent hepatitis B transmission in mothers with high viral load[J].N Engl JMed, 2016, 374 (24) :2324-2334.
|
|
[3]VODKIN I, PATTON H.Management of hepatitis B virus infection during pregnancy[J].Minerva Gastroenterol Dietol, 2014, 60 (4) :205-214.
|
|
[4]LEUNG N.Chronic hepatitis B in Asian women of childbearing age[J].Hepatol Int, 2009, 3 (Suppl 1) :24-31.
|
|
[5]PETROVA M, KAMBUROV V.Breastfeeding and chronic HBVinfection:Clinical and social implications[J].World J Gastroenterol, 2010, 16 (40) :5042-5046.
|
|
[6]XIN X, WANG Y, CHENG J, et al.Seroepidemiological survey of hepatitis B virus infection among 764, 460 women of childbearing age in rural China:A cross-sectional study[J].JClin Virol, 2016, 81:47-52.
|
|
[7]ZHAO SH, HAN LY, ZHANG LH, et al.Study of the harm of HBV infection on mother and fetus and the preventive[J].JNorman Bethune Univ (Med Sci) , 2000, 26 (1) :75. (in Chinese) 赵淑华, 韩丽英, 张立会, 等.乙型肝炎病毒携带者妊娠对母婴的危害及预防措施的研究[J].白求恩医科大学学报, 2000, 26 (1) :75.
|
|
[8]YANG YB, LI XM, ZHOU YS, et al.Association of hepatitis Bvirus infection during pregnancy with mother-child prognosis[J].Chin J Pract Gynecol Obstetr, 2004, 20 (6) :371-372. (in Chinese) 杨越波, 李小毛, 周永生, 等.妊娠合并乙型肝炎病毒感染与母儿预后的关系[J].中国实用妇科与产科杂志, 2004, 20 (6) :371-372.
|
|
[9]TAN HH, LUI HF, CHOW WC.Chronic hepatitis B virus (HBV) infection in pregnancy[J].Hepatol Int, 2008, 2 (3) :370-375.
|
|
[10]SAFIR A, LEVY A, SIKULER E, et al.Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome[J].Liver Int, 2010, 30 (5) :765-770.
|
|
[11]SODERSTROM A, NORKRANS G, LINDH M.Hepatitis B virus DNA during pregnancy and post partum:Aspects on vertical transmission[J].Scand J Infect Dis, 2003, 35 (11-12) :814-819.
|
|
[12]LIN HH, CHEN PJ, CHEN DS, et al.Postpartum subsidence of hepatitis B viral replication in HBe Ag-positive carrier mothers[J].J Med Virol, 1989, 29 (1) :1-6.
|
|
[13]JONAS MM.Hepatitis B and pregnancy:An underestimated issue[J].Liver Int, 2009, 29 (Suppl 1) :133-139.
|
|
[14]RUAN SM, ZHOU J, SHAN ZL, et al.Pregnancy and postpartum hepatitis activity in pregnant women with high viral load of HBV infection[J].Prog Obstet Gynecol, 2018, 27 (6) :458-461. (in Chinese) 阮晟鸣, 周健, 单震丽, 等.HBV感染高病毒载量孕妇孕期及产后肝炎活动情况[J].现代妇产科进展, 2018, 27 (6) :458-461.
|
|
[15]ter BORG MJ, LEEMANS WF, DE MAN RA, et al.Exacerbation of chronic hepatitis B infection after delivery[J].J Viral Hepat, 2008, 15 (1) :37-41.
|
|
[16]CAO YJ, YI W, LIU M, et al.Postpartum observation of changes in liver function of pregnant women with hepatitis B virus infection in immune tolerant phase[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2013, 7 (3) :111-114. (in Chinese) 曹彦君, 易为, 刘敏, 等.免疫耐受期HBV感染的孕妇产后肝功能变化[J/CD].中华实验和临床感染病杂志:电子版, 2013, 7 (3) :111-114.
|
|
[17]WANG XX, HAN GR, JIANG HX, et al.Observation on postpartum changes in liver function of pregnant women with chronic HBV infection[J].Occup Health, 2016, 32 (4) :498-501. (in Chinese) 王习习, 韩国荣, 江红秀, 等.慢性乙型肝炎病毒感染孕妇产后肝功能的变化[J].职业与健康, 2016, 32 (4) :498-501.
|
|
[18]YI W, PAN CQ, LI MH, et al.The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B[J].Am J Gastroenterol, 2018, 113 (5) :686-693.
|
|
[19]LIU J, LEE MH, BATRLA-UTERMANN R, et al.A predictive scoring system for the seroclearance of HBsAg in HBe Ag-seronegative chronic hepatitis B patients with genotype B or C infection[J].J Hepatol, 2013, 58 (5) :853-860.
|
|
[20]ZHOU P.Clinical follow-up analysis of mother to child transmission of hepatitis B[D].Guangzhou:Southern Medical University, 2017:34-35. (in Chinese) 周佩.乙型肝炎母婴传播阻断的临床随访分析[D].广州:南方医科大学, 2017:34-35.
|
|
[21]YUE L, TAN JY, LI SH, et al.Research advances in the mechanism of immune tolerance during pregnancy[J].Matern Child Health Care China, 2012, 27 (5) :784-786. (in Chinese) 岳兰, 谭继英, 李少红, 等.妊娠免疫耐受机制的研究进展[J].中国妇幼保健, 2012, 27 (5) :784-786.
|
|
[22]DING Y, SHENG QJ, MA L, et al.Chronic HBV infection among pregnant women and their infants in Shengyang, China[J].Virol J, 2013, 10 (1) :17.
|
|
[23]WANG SJ, SHENG QJ, WU YY, et al.Comparative study of the serological and virological characteristics in pregnant women with chronic HBV infection between 2016 and 2010[J].Chin J Pract Intern Med, 2017, 37 (12) :1079-1081. (in Chinese) 王岁晶, 盛秋菊, 吴宇宇, 等.慢性乙型肝炎病毒感染孕妇血清学及病毒学特征---沈阳部分地区2016年与2010年对比研究[J].中国实用内科杂志, 2017, 37 (12) :1079-1081.
|
|
[24]GILES ML, VISVANATHAN K, LEWIN SR, et al.Chronic hepatitis B infection and pregnancy[J].Obstet Gynecol Surv, 2012, 67 (1) :37-44.
|
|
[25]AAGAARD-TILLERY KM, SILVER R, DALTON J.Immunology of normal pregnancy[J].Semin Fetal Neonatal Med, 2006, 11 (5) :279-295.
|
|
[26]BETZ AG.Immunology:Tolerating pregnancy[J].Nature, 2012, 490 (7418) :47-48.
|
|
[27]Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese, Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
|
[28]TERRAULT NA, LOK ASF, MCMAHON BJ, et al.Update on prevention, diagnosis, and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J].Hepatology, 2018, 67 (4) :1560-1599.
|
|
[29]European Association for the Study of the Liver.EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure[J].J Hepatol, 2017, 66 (5) :1047-1081.
|
|
[30]SARIN SK, KUMAR M, LAU GK, et al.Asian-Pacific clinical practice guidelines on the management of hepatitis B:A 2015update[J].Hepatol Int, 2016, 10 (1) :1-98.
|
|
[31]DING Y, YOU H, REN H, et al.Consensus on the management of hepatitis B virus infection in women of childbearing age[J].J Clin Hepatol, 2018, 34 (6) :1176-1180. (in Chinese) 丁洋, 尤红, 任红, 等.感染乙型肝炎病毒的育龄女性临床管理共识[J].临床肝胆病杂志, 2018, 34 (6) :1176-1180.
|
|
[32]CHEN HL, LEE CN, CHANG CH, et al.Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus[J].Hepatology, 2015, 62 (2) :375-386.
|
|
[33]CELEN MK, MERT D, AY M, et al.Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection[J].World J Gastroenterol, 2013, 19 (48) :9377-9382.
|
|
[34]JOURDAIN G, NGO-GIANG-HUONG N, HARRISON L, et al.Tenofovir versus placebo to prevent perinatal transmission of hepatitis B[J].N Engl J Med, 2018, 378 (10) :911-923.
|
|
[35]NGUYEN V, TAN PK, GREENUP AJ, et al.Anti-viral therapy for prevention of perinatal HBV transmission:Extending therapy beyond birth does not protect against post-partum flare[J].Aliment Pharmacol Ther, 2014, 39 (10) :1225-1234.
|
|
[36]ZHANG H, PAN CQ, PANG Q, et al.Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice[J].Hepatology, 2014, 60 (2) :468-476.
|
|
[37]FU D, LIU M, YI W, et al.Analysis on 23 cases of liver disease flare of pregnant women with inactive HBV infection[J/CD].Chin J Liver Dis:Electronic Edition, 2015, 7 (2) :49-52. (in Chinese) 付冬, 刘敏, 易为, 等.非活动期HBV感染妇女孕期肝病再活动23例分析[J/CD].中国肝脏病杂志:电子版, 2015, 7 (2) :49-52.
|
|
[38]CHIEN TL, WANG JH, KEE KM, et al.Factors predicting HB-sAg seroclearance and alanine transaminase elevation in HBe Ag-negative hepatitis B virus-infected patients with persistently normal liver function?[J].PLo S One, 2016, 11 (12) :e0166543.
|
|
[39]XU CY, LIU JL, LIU LH, et al.Levels of hepatitis B virus and its antigen in pregnant and non-pregnant women of childbearing age:A comparative analysis[J].Chin J Perinat Med, 2015, 18 (11) :828-831. (in Chinese) 徐陈瑜, 刘景丽, 刘兰华, 等.妊娠和非妊娠育龄妇女体内乙型肝炎病毒及其抗原水平比较[J].中华围产医学杂志, 2015, 18 (11) :828-831.
|
|
[40]MI L, KARSDON J, HUANG WM.Outcomes of eight Chinese-Americans pregnant patients with chronic hepatitis B (CHB) treated with tenofovir DF (TDF) during pregnancy[C].USA, The 61st Annual Meeting of AASLD, Boston, 2010.
|
|
[41]JIANG XN, FAN LY, LI DZ, et al.Clinical trial of telbivudine in the treatment of chronic hepatitis B in patients during the third trimester of pregnancy[J].J Clin Hepatol, 2013, 29 (2) :101-103. (in Chinese) 姜秀浓, 范玲燕, 李德周, 等.替比夫定治疗妊娠晚期慢性乙型肝炎孕妇的临床观察[J].临床肝胆病杂志, 2013, 29 (2) :101-103.
|
|
[42]BIAN Q, WANG M, ZHU YX, et al.Clinical study of nucleoside analogue therapy in pregnant women with chronic hepatitis B with abnormal liver function[J].Beijing Med J, 2016, 38 (12) :1330-1332. (in Chinese) 边茜, 王明, 朱云霞, 等.肝功能异常的慢性乙型肝炎孕妇应用核苷类似物治疗的临床研究[J].北京医学, 2016, 38 (12) :1330-1332.
|
|
[43]HAN GR, CAO MK, ZHAO W, et al.Aprospective andopentable study for the efficacy and safty of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitise B virus infection[J].Hepatology, 2011, 55 (6) :1215-1221.
|
DownLoad: